Canine distemper virus. Serengeti's big cats going to the dogs

Recombinant vaccines against the mononegaviruses--what we have learned from animal disease controls

The mononegaviruses include a number of highly contagious and severe disease-causing viruses of both animals and humans. For the control of these viral diseases, development of vaccines, either with classical methods or with recombinant DNA virus vectors, has been attempted over the years. Recently reverse genetics of mononegaviruses has been developed and used to generate infectious viruses possessing genomes derived from cloned cDNA in order to study the consequent effects of viral gene manipulations on phenotype. This technology allows us to develop novel candidate vaccines. In particular, a variety of different attenuation strategies to produce a range of attenuated mononegavirus vaccines have been studied. In addition, because of their ideal nature as live vaccines, recombinant mononegaviruses expressing foreign proteins have also been produced with the aim of developing multivalent vaccines against more than one pathogen. These recombinant mononegaviruses are currently under evaluation as new viral vectors for vaccination. Reverse genetics could have great potential for the preparation of vaccines against many mononegaviruses.

Applications of veterinary medicine toin situconservation efforts

Wildlife conservation efforts are increasingly faced with declining, overcrowded or fragmented populations, environmental contamination, and the introduction of new species of either competitors or pathogens. These efforts are coming under increased public scrutiny in their attempt to balance human social and economic needs with those of wildlife. The integration of veterinary medicine as part of a multidisciplinary approach to conservation can assist in the successful planning, implementation and evaluation of conservation projects. Beyond the role of immobilizing animals, veterinarians can contribute to assessing and monitoring the health of wild populations, and can train others in modern approaches to working with and caring for wildlife.

First evidence of canine distemper in Brazilian free-ranging felids

Serum samples from 19 jaguars (Panthera onca), nine pumas (Puma concolor), and two ocelots (Leopardus pardalis) were collected between January 1999 and March of 2005 and tested for presence of canine distemper virus (CDV). All cats were free-ranging animals living in two protected areas in the Brazilian Atlantic Forest. In addition, 111 domestic dogs from nearby areas were sampled for CDV. Our results show the first evidence of CDV exposure in Brazilian free-ranging felids. From the 30 samples analyzed, six jaguars and one puma were tested seropositive for CDV. All seropositive large felids were from Ivinhema State Park, resulting in 31.5% of the sampled jaguars or 60% of the total jaguar population in Ivinhema State Park, and 11.28% of the sampled pumas. From the total 111 domestic dogs sampled, 45 were tested seropositive for CDV. At Morro do Diabo State Park, 34.6% of the dogs sampled were positive for CDV, and 100% at Ivinhema State Park. Canine distemper virus in wild felids seems to be related with home range use and in close association with domestic dogs living in nearby areas.

Perfil de restrição de um fragmento do gene da hemaglutinina amplificado pela RT-PCR a partir de estirpes vacinais e selvagens do vírus da cinomose canina

Fragmentos com 721 pares de bases do gene da hemaglutinina (H) do vírus da cinomose canina (CDV), amplificados pela RT-PCR a partir de três estirpes vacinais (Snyder Hill, Onderstepoort e Rockborn) e de 27 amostras de campo, provenientes de cães com cinomose, foram clivados com as endonucleases Hinf I and Rsa I. A seleção das enzimas foi realizada por meio de análises in silico de seqüências do CDV depositadas em bases públicas de dados. Tanto as estirpes vacinais quanto as amostras selvagens do CDV apresentaram com a enzima Hinf I o mesmo perfil de restrição, confirmando a identidade do fragmento amplificado pela RT-PCR, uma vez que todas as estirpes com seqüências disponíveis (GenBank) têm sítios de restrição para essa enzima nas mesmas posições. O perfil de restrição das estirpes vacinais Snyder Hill e Onderstepoort, que diferem entre si, foi confirmado com a enzima Rsa I que também clivou a estirpe Rockborn nas mesmas posições que a estirpe Snyder Hill. Todas as 27 amostras de campo do CDV apresentaram com a enzima Rsa I o mesmo perfil de restrição, indicando conservar os mesmos sítios de restrição para essa enzima. O perfil das amostras de campo foi diferente daquele obtido nas três estirpes vacinais. Os perfis de restrição do gene que codifica a hemaglutinina do CDV, gerados pela enzima Rsa I, sugerem diferenças moleculares entre as estirpes vacinais e as selvagens circulantes na região norte do estado do Paraná e abrem a perspectiva da elaboração de análises moleculares comparativas mais complexas, como o seqüenciamento de todo o gene H, de estirpes do CDV identificadas em diferentes regiões brasileiras.

Seroprevalence of canine distemper virus in cats

A seroepidemiological survey of canine distemper virus (CDV) infection in Asian felids revealed that the prevalence of antibodies varied depending on region and, in some cases, exposure to dogs. The serologic pattern in cats with antibodies indicated that they had likely been exposed to field strains rather than typical CDV vaccine strains.

Establishment of a rescue system for canine distemper virus

Canine distemper virus (CDV) has been rescued from a full-length cDNA clone. Besides Measles virus (MV) and Rinderpest virus, a third morbillivirus is now available for genetic analysis using reverse genetics. A plasmid p(+)CDV was constructed by sequential cloning using the Onderstepoort vaccine strain large-plaque-forming variant. The presence of a T7 promoter allowed transcription of full-length antigenomic RNA by a T7 RNA polymerase, which was provided by a host range mutant of vaccinia virus (MVA-T7). Plasmids expressing the nucleocapsid protein, the phosphoprotein, and the viral RNA-dependent RNA polymerase, also under control of a T7 promoter, have been generated. Infection of HeLa cells with MVA-T7 and subsequent transfection of p(+)CDV plus the helper plasmids led to syncytium formation and release of infectious recombinant (r) CDV. Comparison of the rescued virus with the parental virus revealed no major differences in the progression of infection or in the shape and size of syncytia. A genetic tag, consisting of two nucleotide changes within the coding region of the L protein, has been identified in the rCDV genome. Expression by rCDV of all the major viral structural proteins has been demonstrated by immunofluorescence.

Antigenic differences in the H proteins of canine distemper viruses

Antigenic properties between new Japanese field isolates and vaccine strains of canine distemper virus (CDV) have been compared using four monoclonal antibodies (MAbs) (JD-5, JD-7, JD-11 and d-7) against the hemagglutinin (H) proteins of CDV. JD-5, JD-7 and JD-11 are newly established antibodies. Three MAbs, namely d-7, JD-5 and JD-11, reacted similarly to all the CDV strains examined. However, JD-7 reacted much more strongly with the vaccine strains and an old field isolate than the recent field isolates in immunofluorescence, radio immunoprecipitation and virus neutralization assays. These results indicate that an antigenic region in the H protein, concerned with neutralization and recognized by JD-7, has been altered in the recent field isolates.

Canine distemper virus infection in binturongs (Arctictis binturong)

Two binturongs (Arctictis binturong) kept in outdoor exhibits at Everland Zoological Gardens in Korea died within 10 days of the onset of clinical signs that included depression, dyspnoea, diarrhoea and convulsions. On necropsy, the significant gross findings were limited to the lungs and the gastrointestinal tract. Proteus vulgaris was isolated from the lung of one animal. Histopathologically, diffuse severe bronchointerstitial pneumonia with secondary bacterial infection was noted in the lungs. Intracytoplasmic eosinophilic inclusion bodies were seen in the lining epithelium of the bronchi, bronchioles, small and large intestines, renal pelvis and urinary bladder. Canine distemper virus (CDV)-specific antigens were demonstrated in frozen sections of the lungs by the direct immunofluorescence technique. This is believed to be the first confirmed report of CDV infection in binturongs.

Canine distemper virus DNA vaccination induces humoral and cellular immunity and protects against a lethal intracerebral challenge

We have studied the immune responses to the two glycoproteins of the Morbillivirus canine distemper virus (CDV) after DNA vaccination of BALB/c mice. The plasmids coding for both CDV hemagglutinin (H) and fusion protein (F) induce high levels of antibodies which persist for more than 6 months. Intramuscular inoculation of the CDV DNA induces a predominantly immunoglobulin G2a (IgG2a) response (Th1 response), whereas gene gun immunization with CDV H evokes exclusively an IgG1 response (Th2 response). In contrast, the CDV F gene elicited a mixed, IgG1 and IgG2a response. Mice vaccinated (by gene gun) with either the CDV H or F DNA showed a class I-restricted cytotoxic lymphocyte response. Immunized mice challenged intracerebrally with a lethal dose of a neurovirulent strain of CDV were protected. However, approximately 30% of the mice vaccinated with the CDV F DNA became obese in the first 2 months following the challenge. This was not correlated with the serum antibody levels.

Canine distemper antibodies in lions of the Masai Mara

Canine distemper virus (CDV) has been implicated in some recent deaths of lions, which showed clinical signs of distemper, in the the Serengeti plain. Similar clinical findings have since been reported in lions of the Masai Mara. Fifty-five per cent of serum samples obtained from wild lions of the Masai Mara have been found to contain neutralising antibody to CDV, indicating that they had been exposed to the virus. Adult orphan lions kept in captivity, were vaccinated with the live attenuated Onderstepoort strain of CDV. The results indicated that the vaccine is both safe and immunogenic, and may be potentially useful for the prophylactic vaccination of lions at high risk.

Emerging diseases--what veterinarians need to know

The recent increase in emerging diseases can be attributed to a number of factors, all of which relate to some form of alteration in the way etiologic agents move around. Some of these factors responsible for altered agent trafficking include actual transport to a susceptible population or new species, environmental disruption that facilitates exchange of microbes, and a husbandry change that promotes new ways for microbes to move around. Given the exponential growth of the human population and all the attendant implications, including the mobility of this population, the ecological disruption that is accompanying the overall increase, and the necessity of exploring new agricultural technologies to feed a burgeoning population, it is a certainty that altered agent trafficking will not only continue but will undoubtedly increase. Veterinarians should be aware of the role they will be expected to play in this field.

Rinderpest and other animal morbillivirus infections: comparative aspects and recent developments

The genus morbillivirus presently comprises measles virus of man, rinderpest virus (RPV), peste des petits ruminants virus (PPRV), and canine distemper virus (CDV). 'Emerging' morbilliviruses, such as phocid distemper virus (PDV) of seals, dolphin (DMV) and porpoise morbillivirus (PMV) have probably been present for a long period of time and outbreaks are possibly related to introduction into a highly susceptible population and/or be the result of interspecies transmission. In this review some comparative aspects of morbillivirus infections, particularly with respect to rinderpest and canine distemper viruses, are presented. Topics include pathogenesis, epidemiology, molecular phylogeny, diagnosis and prophylaxis. Recent developments in molecular biology have created tools which have enabled us to achieve a better understanding of morbillivirus infections at the nucleic acid level ('molecular epidemiology') while recombinant DNA technology has allowed new bivalent recombinant vaccines with improved heat stability to be produced.

Parasite prevalence in free-ranging farm cats, Felis silvestris catus

No animals tested were positive for feline leukemia virus antigen and Chlamydia psittaci antibodies, but all were positive for antibodies to feline calicivirus (FCV), feline herpesvirus 1 (FHV1) and rotavirus. They had antibodies to feline parvovirus (96%), feline coronavirus (84% and cowpox virus (2%). Antibody to feline immunodeficiency virus (FIV) was found in 53% of animals, which were less likely to be infected with Haemobartonella felis, and had higher FHV antibody titres than cats without FIV. FCV was isolated from 51% cats and FHV1 and feline reovirus each from 4%. H. felis was present in 42% of animals, and antibody to Toxoplasma gondii in 62%. Clinical abnormality had a significant association with FIV and feline calicivirus infections, but sex, age, social status and feeding group had no significant association with prevalence of any parasites. Toxocara cati and Toxascaris leonina eggs were found, respectively, in 91% and 82% of animals tested.

Phylogenetic evidence of canine distemper virus in Serengeti's lions

Recently an epizootic, reported to be due to a morbillivirus infection, affected the lion population of the Tanzanian Serengeti National Park. A morbillivirus phosphoprotein (P) gene fragment was amplified by PCR from tissue samples of several affected lions. Sequencing of the amplificates and subsequent phylogenetic analyses revealed that a wild-type strain of canine distemper morbillivirus (CDV) was involved. Vaccination of the local domestic dog population with proven safe CDV vaccines is proposed.